History

COMPANY / History

History

2010s

2016
Feb

Registered on the Patent List for Medicine at the Korea Food & Drugs Administration

Jan

Changed Name of Company to Biosolution Co., Ltd.

2015
Oct

Received License for KeraHeal-Allo, an Allogeneic Keratinocyte Therapy Product

Jul

Grant Awarded by the Ministry of Health and Welfare
(Development of bead-type bio-cartilage using scaffold-free tissue engineering technology)

Jan

Grant Awarded by the Ministry of Health and Welfare (Study on practical use of gene-modified stem cell therapy LipoCartigen) 

2014
Nov

Expansion/Transition of the Manufacturing Facility(GMP Facility)

Oct

Grant Awarded by the National Coordinating Center for Global Cosmetics R&D
(Development of a new animal alternative method to study cosmeceutical efficacy using full thickness skin model of Korean origin)

2013
Nov

Received Approval for Re-evaluation of KeraHeal

Oct

Received Approval for Phase 2 Clinical Trials on CartiLife

Apr

Received Approval for Phase 3 Clinical Trials on KeraHeal-Allo

Feb

Grant Awarded by MFDS
(Prevalidative evaluation of alternative methods about skin, cornea and mucosa irritation)

2012
Dec

Changed Name of Company to MCTT Bio Co., Ltd.

Jul

Received Approval for Phase 1 Clinical Trials on CartiLife 

2011
Feb

Received Approval for Phase 1/2 Clinical Trials on KeraHeal-Allo

Jan

Completed Safety Evaluations on Non-Clinical Trials for STeM水 due to notifications by the Korea Food & Drug Administration

2000s

2010

Launched STeM水, Extract from Stem Cell Culture Media

2009

KeraHeal Approved for Coverage under the Occupational Health and Safety Insurance

2006

Received License for KeraHeal, an Autologous Keratinocyte Therapy Product

2000

Established Company and Received Approval for the R&D Center